Streetbeat News

Price Targets

USGO

HC Wainwright & Co. has reiterated its Buy rating on US Goldmining (NASDAQ:USGO) and maintained a price target of $23.5.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:13 am

PAGS

Morgan Stanley has downgraded PagSeguro Digital from Equal-Weight to Underweight and reduced its price target from $14 to $6.5.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:11 am

STNE

Morgan Stanley has downgraded StoneCo from Equal-Weight to Underweight and significantly lowered its price target from $16.5 to $7.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:08 am

BBWI

Morgan Stanley has maintained an Overweight rating on Bath & Body Works but has lowered the price target from $56 to $51.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:05 am

ARWR

HC Wainwright & Co. has reiterated its Buy rating for Arrowhead Pharma, maintaining a price target of $60. This suggests confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:04 am

CORZ

HR

WEST

Insider purchases were made in Core Scientific, Healthcare Realty Trust, and Westrock Coffee, indicating potential confidence in these companies. Core Scientific received a Buy rating from Needham with a $16 price target.

Portfolio Pulse from Avi Kapoor

September 05, 2024 | 11:03 am

IGMS

HC Wainwright & Co. analyst Robert Burns maintains a Neutral rating on IGM Biosciences and lowers the price target from $12 to $11.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:02 am

CMA

Keefe, Bruyette & Woods has upgraded Comerica (NYSE:CMA) from Market Perform to Outperform, raising the price target from $50 to $69.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 11:02 am

ZURA

HC Wainwright & Co. has initiated coverage on Zura Bio with a Neutral rating and set a price target of $5.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:59 am

NMRK

Keefe, Bruyette & Woods has upgraded Newmark Group (NASDAQ:NMRK) from Market Perform to Outperform, raising the price target from $13.5 to $16.5.

Portfolio Pulse from Benzinga Newsdesk

September 05, 2024 | 10:58 am